900174-94-9 Usage
Uses
Used in Pharmaceutical Research:
(R)-4-(isopropylsulfonyl)-3-(pyrrolidin-2-yl)benzeneamine is used as a research compound for its potential applications in the development of new pharmaceuticals. Its unique structure allows for selective interactions with biological systems, which can be harnessed to create targeted therapies.
Used in Drug Development:
In the drug development industry, (R)-4-(isopropylsulfonyl)-3-(pyrrolidin-2-yl)benzeneamine is used as a lead compound to explore its potential in creating novel medications. Its stereochemistry and functional groups provide a foundation for understanding the structure-activity relationships of related compounds, which can be crucial in the design of effective drugs.
Used in Medicinal Chemistry:
(R)-4-(isopropylsulfonyl)-3-(pyrrolidin-2-yl)benzeneamine serves as a valuable compound in medicinal chemistry for studying the interactions between small molecules and biological targets. Its properties can help researchers understand how these interactions can be modulated for therapeutic benefit.
Used in Pharmacology:
In pharmacology, (R)-4-(isopropylsulfonyl)-3-(pyrrolidin-2-yl)benzeneamine is used as a tool to investigate the mechanisms of drug action and the potential side effects of new compounds. Its unique structure can provide insights into how drugs interact with biological systems and how their efficacy and safety can be optimized.
Check Digit Verification of cas no
The CAS Registry Mumber 900174-94-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,7 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 900174-94:
(8*9)+(7*0)+(6*0)+(5*1)+(4*7)+(3*4)+(2*9)+(1*4)=139
139 % 10 = 9
So 900174-94-9 is a valid CAS Registry Number.
900174-94-9Relevant academic research and scientific papers
BICYCLIC LACTAM FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
-
Page/Page column 135, (2008/12/07)
The present invention provides novel bicyclic lactams derivatives, and analogues thereof, of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, B, C, W, Y, Z1, Z2, Z3, Z4, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS
-
Page/Page column 143-144, (2008/06/13)
The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
